Results 11 to 20 of about 21,037 (206)

Polyglutamine diseases

open access: yesCurrent Opinion in Neurobiology, 2021
Polyglutamine diseases are a collection of nine CAG trinucleotide expansion disorders, presenting with a spectrum of neurological and clinical phenotypes. Recent human, mouse and cell studies of Huntington's disease have highlighted the role of DNA repair genes in somatic expansion of the CAG repeat region, modifying disease pathogenesis.
Emma L Bunting, J. Hamilton, S. Tabrizi
semanticscholar   +4 more sources

Polyglutamine Repeats in Neurodegenerative Diseases. [PDF]

open access: yesAnnual Review of Pathology: Mechanisms of Disease, 2019
Among the age-dependent protein aggregation disorders, nine neurodegenerative diseases are caused by expansions of CAG repeats encoding polyglutamine (polyQ) tracts.
A. Lieberman, V. Shakkottai, R. Albin
semanticscholar   +4 more sources

Polyglutamine tracts regulate autophagy [PDF]

open access: yesAutophagy, 2017
Expansions of polyglutamine (polyQ) tracts in different proteins cause 9 neurodegenerative conditions, such as Huntington disease and various ataxias. However, many normal mammalian proteins contain shorter polyQ tracts. As these are frequently conserved in multiple species, it is likely that some of these polyQ tracts have important but unknown ...
A. Ashkenazi   +10 more
semanticscholar   +4 more sources

Polyglutamine pathogenesis [PDF]

open access: greenPhilosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 1999
An increasing number of neurodegenerative disorders have been found to be caused by expanding CAG triplet repeats that code for polyglutamine. Huntington's disease (HD) is the most common of these disorders and dentato-rubral-pallidoluysian atrophy (DRPLA) is very similar to HD, but is caused by mutation in a different gene, making them good models to ...
Christopher A. Ross   +8 more
openalex   +4 more sources

Studying polyglutamine diseases in Drosophila [PDF]

open access: yesExperimental Neurology, 2015
Polyglutamine (polyQ) diseases are a family of dominantly transmitted neurodegenerative disorders caused by an abnormal expansion of CAG trinucleotide repeats in the protein-coding regions of the respective disease-causing genes. Despite their simple genetic basis, the etiology of these diseases is far from clear.
Zhen Xu   +3 more
semanticscholar   +4 more sources

Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo [PDF]

open access: bronzeCell, 1997
Eberhard Scherzinger   +9 more
openalex   +2 more sources

Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?

open access: yesCell Death and Disease, 2021
Stress granules (SGs) are membraneless cell compartments formed in response to different stress stimuli, wherein translation factors, mRNAs, RNA-binding proteins (RBPs) and other proteins coalesce together.
Adriana Marcelo   +4 more
semanticscholar   +1 more source

ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats [PDF]

open access: goldGenes & Development, 2002
Expansion of CAG trinucleotide repeats that encode polyglutamine is the underlying cause of at least nine inherited human neurodegenerative disorders, including Huntington's disease and spinocerebellar ataxias. PolyQ fragments accumulate as aggregates in
Hideki Nishitoh   +8 more
openalex   +2 more sources

Polyglutamine Disease: Acetyltransferases Awry [PDF]

open access: bronzeCurrent Biology, 2002
Recent evidence indicates that inhibition of histone acetyltransferases may be a primary cause of cellular pathogenesis in polyglutamine diseases such as Huntington disease; the results raise the possibility that pharmacologic manipulation of protein acetylation levels could be of therapeutic benefit.
Robert E. Hughes
openalex   +3 more sources

Silencing Polyglutamine Degeneration with RNAi [PDF]

open access: yesNeuron, 2005
Nine dominantly inherited neurodegenerative diseases are caused by expansion of a CAG repeat encoding glutamine. An important development in the study of such "polyglutamine" diseases was the realization that merely shutting off expression of a disease-encoding transgene could arrest progression in animal models with significant disease pathology. Such
Albert R. La Spada   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy